Stay updated on Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The website has been updated from version 2.9.7 to 2.10.0, indicating a new release with potential enhancements or features.
    Difference
    0.2%
    Check dated 2024-07-23T13:59:10.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T07:01:09.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-07-02T12:25:37.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-27T09:17:48.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-26T08:24:11.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value 'Not provided' for the Progression Free Survival [Time Frame: 16 Week] has been updated to '(Submitted: 2017-10-06)' which indicates a recent submission and change in the data for this specific outcome measure in the study evaluating Neratinib versus Lapatinib Plus Capecitabine for ErbB2 Positive Advanced Breast Cancer.
    Difference
    4%
    Check dated 2024-06-25T07:59:22.000Z thumbnail image

Stay in the know with updates to Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial page.